Clinical results of radiofrequency hyperthermia for malignant liver tumors

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 2, 1997, Pages 359-365

  Nagata, Yasushi ^a   Hiraoka, Masahiro ^a   Nishimura, Yasumasa ^a   Masunaga, Shinitirou ^a   Mitumori, Michihide ^a   Okuno, Yoshishige ^a   Fujishiro, Masayo ^a   Kanamori, Shuichi ^a   Horii, Naotoshi ^a   Akuta, Keizo ^a   Sasai, Keisuke ^a   Abe, Mitsuyuki ^a   Fukuda, Yoshihiro ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Liver tumor; Radiofrequency hyperthermia; Thermometry

Indexed keywords

DOXORUBICIN; MITOMYCIN; PICIBANIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAT NECROSIS; FEMALE; HEMATOMA; HUMAN; HYPERTHERMIC THERAPY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER NECROSIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; PNEUMOTHORAX; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; STOMACH ULCER; THERMOMETRY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOOD PRESSURE; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; THERMOGRAPHY;

EID: 0030789336     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00625-6     Document Type: Article

References (16)

1. Abe, M.; Hiraoka, M.; Takahashi, M., et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 58:1589-1595; 1986.
2. Hiraoka, M.; Jo, S.; Dodo, Y.; Ono, K.; Nishida, M.; Abe, M. Clinical results of radiofrequency hyperthermia combined with radiation in the treatment of radioresistant cancers. Cancer 54:2898-2904; 1984.
3. Hiraoka, M.; Nishimura, Y.; Nagata, Y.; Mitsumori, M., et al. Site-specific phase I, II trials of hyperthermia at Kyoto University. Int. J. Hyperthermia 10:403-410; 1994.
4. Kim, B. S.; Chung, H. C.; Seong, J. S.; Suh, C. O.; Kim, G. E. Phase II trial for combined external radiotherapy and hyperthermia for unresectable hepatoma. Cancer Chemother. Pharmacol. 31:119-127; 1992.
5. Maeta, M.; Kaibara, N.; Nakashima, K.; Kobayashi, M.; Yoshikawa, T.; Okamoto, A.; Sugiyama, A. A case-matched control study of intrahepatoarterial chemotherapy in combination with or without regional hyperthermia for treatment of primary and metastaic hepatic tumors. Int. J. Hyperthermia 10:51-58; 1994.
6. 1-weighted MR sequences. J. Magn. Reson. Imag. 4:65-70; 1994.
7. Nagata, Y.; Yamamoto, K.; Hiraoka, M.; Abe, M.; Takahashi, M.; Akuta, K., et al. Monitoring liver tumor therapy with 18F-FDG positron emission tomography. J Comput Assist Tomogr 14:370-374; 1990.
8. Nagata, Y.; Hiraoka, M.; Abe, M.; Akuta, K.; Takahashi, M.; Jo, S., et al. Radiofrequency thermotherapy for malignant liver tumors. Cancer 65:1730-1736; 1990.
9. Nagata, Y.; Abe, M.; Hiraoka, M.; Nishimura, Y.; Akuta, K.; Takahashi, M., et al. Radiofrequency hyperthermia and radiotherapy for malignant liver tumors. In: T. Tobe. Primary liver cancer in Japan. Tokyo: Springer-Verlag; 1992:315-325.
10. Ritchie, K. P.; Keller, B. M.; Syed, K. M.; Lepock, J. R. Hyperthermia-induced protein denaturation in liver, muscle, and lens tissue as determined by differential scanning calorimetry. Int. J. Hyperthermia 10:605-618; 1994.
11. Seong, J.; Lee, H. S.; Han, K. S.; Chon, C. Y.; Suh, C. O.; Kim, G. E. Combined treatment of radiotherapy and hyperthermia for unresectable hepatocelular carcinoma. Yonsei. Med. J. 35:252-259; 1994.
12. Ucida, A.; Hoshino, T. Clinical studies on cell-mediated immunity in patients with malignant disease. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Cancer 45:476-483; 1980.
13. Uchida, A.; Micksche, M. Intrapleural administration of OK432 in cancer patients: Activation of NK cells and reduction of suppressor cells. Int. J. Cancer 31:1-5; 1983.
14. Yumoto, Y.; Jinno, K.; Tokuyama, K., et al. Transcatheter arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma. Int. J. Hyperthermia 7:7-17; 1991.
15. Zou, Y. Y.; Ueno, M.; Yamagishi, M.; Horikoshi, I. Targetting behavior of hepatic artery injected temperature sensitive liposomal adriamycin on tumor-bearing rats. Sel. Cancer Ther. 6:119-127; 1990.
16. Zou, Y.; Yamagishi, M.; Horikoshi, I.; Ueno, M.; Gu, X. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Cancer Res. 53:3046-3051; 1993.